Cha AI Healthcare Co., Ltd. (KRX:025620)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,010.00
+160.00 (3.30%)
Aug 11, 2026, 3:30 PM KST

Cha AI Healthcare Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7,4917,30515,67516,0896,24614,978
Revenue Growth
-38.13%-53.40%-2.57%157.58%-58.30%-50.92%
Gross Profit
2,0252,0647,3517,966904.53716.44
Operating Income
-7,436-7,702-6,728-9,354-7,983-18,133
Net Income
-913.091,367-9,493-6,797-21,435-38,564
Earnings Per Share
-83.07180.75-2122.00-1560.23-7588.09-13187.50
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
35,49742,0404,0075,00310,5048,301
Total Debt
28,66030,5655,2862,7822,7548,601
Net Cash (Debt)
6,83711,475-1,2792,2217,750-299.74
Net Cash Growth
----71.34%--
Net Cash Per Share
622.021517.44-285.99509.772743.53-102.50

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5,934-6,712-6,913-9,861-4,982-3,490
Capital Expenditures
-74.71--214.07-86.12-919.12-241.96
Free Cash Flow
-6,009-6,712-7,128-9,947-5,901-3,732
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
27.03%28.26%46.90%49.51%14.48%4.78%
Operating Margin
-99.26%-105.44%-42.92%-58.14%-127.81%-121.07%
Pretax Margin
-11.99%18.71%-52.84%-37.02%-312.37%-239.87%
Profit Margin
-12.19%18.71%-60.56%-42.24%-343.16%-257.48%
FCF Margin
-80.21%-91.88%-45.47%-61.83%-94.47%-24.92%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-141.89----
Forward PE
-13.4213.4213.4213.4213.42
PS Ratio
11.7826.551.101.513.725.12